Legend Biotechcorp Stock Alpha and Beta Analysis

LEGN Stock  USD 41.41  1.91  4.84%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Legend BiotechCorp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Legend BiotechCorp over a specified time horizon. Remember, high Legend BiotechCorp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Legend BiotechCorp's market risk premium analysis include:
Beta
1.81
Alpha
(0.69)
Risk
2.59
Sharpe Ratio
(0.28)
Expected Return
(0.72)
Please note that although Legend BiotechCorp alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Legend BiotechCorp did 0.69  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Legend BiotechCorp stock's relative risk over its benchmark. Legend BiotechCorp has a beta of 1.81  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Legend BiotechCorp will likely underperform. At this time, Legend BiotechCorp's Book Value Per Share is very stable compared to the past year. As of the 24th of May 2024, Tangible Book Value Per Share is likely to grow to 6.58, while Enterprise Value Over EBITDA is likely to drop (24.01).

Enterprise Value

5.19 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Legend BiotechCorp Backtesting, Legend BiotechCorp Valuation, Legend BiotechCorp Correlation, Legend BiotechCorp Hype Analysis, Legend BiotechCorp Volatility, Legend BiotechCorp History and analyze Legend BiotechCorp Performance.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Legend BiotechCorp Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Legend BiotechCorp market risk premium is the additional return an investor will receive from holding Legend BiotechCorp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Legend BiotechCorp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Legend BiotechCorp's performance over market.
α-0.69   β1.81

Legend BiotechCorp expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Legend BiotechCorp's Buy-and-hold return. Our buy-and-hold chart shows how Legend BiotechCorp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Legend BiotechCorp Market Price Analysis

Market price analysis indicators help investors to evaluate how Legend BiotechCorp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Legend BiotechCorp shares will generate the highest return on investment. By understating and applying Legend BiotechCorp stock market price indicators, traders can identify Legend BiotechCorp position entry and exit signals to maximize returns.

Legend BiotechCorp Return and Market Media

The median price of Legend BiotechCorp for the period between Sat, Feb 24, 2024 and Fri, May 24, 2024 is 55.14 with a coefficient of variation of 16.0. The daily time series for the period is distributed with a sample standard deviation of 8.66, arithmetic mean of 54.14, and mean deviation of 7.67. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance Report
03/19/2024
2
Johnson Johnsons Carvykti Stands Ahead Of Bristol Myers Rival Blood Cancer Therapy With FDA Approval For Wider Population
04/08/2024
3
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
04/11/2024
4
Legend Biotech Reaches New 1-Year Low at 49.13 - Defense World
04/18/2024
5
CARVYKTI Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
04/22/2024
6
Should You Buy Legend Biotech Ahead of Earnings
05/09/2024
7
Some Shareholders Feeling Restless Over Legend Biotech Corporations PS Ratio
05/13/2024
8
Legend Biotech Corp Q1 2024 Earnings Call Transcript Highlights Soaring CARVYKTI Sales ...
05/14/2024
9
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
05/23/2024

About Legend BiotechCorp Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Legend or other stocks. Alpha measures the amount that position in Legend BiotechCorp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover44.491.998.177.76
Days Of Inventory On Hand2.0457.8243.0845.23

Legend BiotechCorp Upcoming Company Events

As portrayed in its financial statements, the presentation of Legend BiotechCorp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Legend BiotechCorp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Legend BiotechCorp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Legend BiotechCorp. Please utilize our Beneish M Score to check the likelihood of Legend BiotechCorp's management manipulating its earnings.
4th of April 2024
Upcoming Quarterly Report
View
16th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Legend BiotechCorp

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:
Check out Legend BiotechCorp Backtesting, Legend BiotechCorp Valuation, Legend BiotechCorp Correlation, Legend BiotechCorp Hype Analysis, Legend BiotechCorp Volatility, Legend BiotechCorp History and analyze Legend BiotechCorp Performance.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Legend BiotechCorp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Legend BiotechCorp technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Legend BiotechCorp trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...